[go: up one dir, main page]

MX2009001590A - Asociacion de un inhibidor de corriente sinusal if y de un beta-bloqueante. - Google Patents

Asociacion de un inhibidor de corriente sinusal if y de un beta-bloqueante.

Info

Publication number
MX2009001590A
MX2009001590A MX2009001590A MX2009001590A MX2009001590A MX 2009001590 A MX2009001590 A MX 2009001590A MX 2009001590 A MX2009001590 A MX 2009001590A MX 2009001590 A MX2009001590 A MX 2009001590A MX 2009001590 A MX2009001590 A MX 2009001590A
Authority
MX
Mexico
Prior art keywords
association
sinus node
beta blocker
current inhibitor
inhibitor
Prior art date
Application number
MX2009001590A
Other languages
English (en)
Inventor
Guy Lerebours-Pigeonniere
Jean-Henri Calvet
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39666229&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009001590(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of MX2009001590A publication Critical patent/MX2009001590A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Asociación de un inhibidor de corriente sinusal If y de un ß-bloqueante, así como las compasiones farmacéuticas que la contienen. Medicamentos.
MX2009001590A 2008-02-14 2009-02-12 Asociacion de un inhibidor de corriente sinusal if y de un beta-bloqueante. MX2009001590A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0800800A FR2927538B1 (fr) 2008-02-14 2008-02-14 Association d'un inhibiteur du courant if sinusal et d'un beta-bloquant.

Publications (1)

Publication Number Publication Date
MX2009001590A true MX2009001590A (es) 2009-08-24

Family

ID=39666229

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009001590A MX2009001590A (es) 2008-02-14 2009-02-12 Asociacion de un inhibidor de corriente sinusal if y de un beta-bloqueante.

Country Status (37)

Country Link
US (1) US8217030B2 (es)
EP (2) EP2090303B1 (es)
JP (2) JP2009191069A (es)
KR (1) KR101078133B1 (es)
CN (1) CN101507726B (es)
AP (1) AP2010005366A0 (es)
AR (1) AR070416A1 (es)
AU (1) AU2009200393B2 (es)
BR (1) BRPI0900470A2 (es)
CA (1) CA2654210C (es)
CO (1) CO6290712A2 (es)
CR (1) CR11628A (es)
CU (1) CU24007B1 (es)
CY (1) CY1114113T1 (es)
DK (1) DK2090303T3 (es)
EA (1) EA200900137A1 (es)
EC (1) ECSP10010402A (es)
ES (1) ES2421893T3 (es)
FR (1) FR2927538B1 (es)
GE (1) GEP20115261B (es)
HN (1) HN2010001608A (es)
HR (1) HRP20130617T1 (es)
IL (1) IL207386A0 (es)
MA (1) MA31132B1 (es)
ME (1) ME01014B (es)
MX (1) MX2009001590A (es)
MY (1) MY149122A (es)
NI (1) NI201000139A (es)
NZ (1) NZ574843A (es)
PL (1) PL2090303T3 (es)
PT (1) PT2090303E (es)
RS (1) RS52834B (es)
SG (1) SG155130A1 (es)
SI (1) SI2090303T1 (es)
UA (1) UA99817C2 (es)
WO (1) WO2009115669A1 (es)
ZA (1) ZA200900894B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2961105B1 (fr) * 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
US9674435B1 (en) * 2016-07-06 2017-06-06 Lawrence Maxwell Monari Virtual reality platforms for capturing content for virtual reality displays
KR20190001340A (ko) * 2017-06-27 2019-01-04 에리슨제약(주) 이바브라딘을 포함하는 서방성 약제학적 조성물 및 이의 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05503510A (ja) * 1989-11-21 1993-06-10 セプラカー・インコーポレーテツド 光学的に純粋な（ｓ）―アテノロールを含む組成物と方法
FR2681862B1 (fr) 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
WO2003024457A1 (en) * 2001-09-11 2003-03-27 Asahi Kasei Kabushiki Kaisha Medicinal composition for prevention of or treatment for cerebrovascular disorder and cardiopathy
ES2211846T3 (es) 2002-07-25 2004-07-16 BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG Uso de cilobradina o sus sales farmaceuticamente aceptables para el tratamiento o la prevencion de la insuficiencia cardiaca.
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
FR2894826B1 (fr) * 2005-12-21 2010-10-22 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent
CN101095682A (zh) * 2007-07-23 2008-01-02 北京本草天源药物研究院 一种伊伐布雷定或其药用盐的口服制剂

Also Published As

Publication number Publication date
NI201000139A (es) 2011-01-10
ME01014B (me) 2012-10-20
US8217030B2 (en) 2012-07-10
PL2090303T3 (pl) 2013-07-31
AP2010005366A0 (en) 2010-08-31
HK1137341A1 (en) 2010-07-30
NZ574843A (en) 2011-07-29
MA31132B1 (fr) 2010-02-01
JP2012211179A (ja) 2012-11-01
CN101507726B (zh) 2012-03-28
SG155130A1 (en) 2009-09-30
WO2009115669A1 (fr) 2009-09-24
RS52834B (sr) 2013-10-31
EP2090303B1 (fr) 2013-05-01
CU20100162A7 (es) 2011-10-31
FR2927538A1 (fr) 2009-08-21
CO6290712A2 (es) 2011-06-20
ES2421893T3 (es) 2013-09-06
UA99817C2 (ru) 2012-10-10
BRPI0900470A2 (pt) 2009-09-29
AU2009200393B2 (en) 2013-11-07
CR11628A (es) 2010-11-22
KR101078133B1 (ko) 2011-10-28
EP2409694A1 (fr) 2012-01-25
KR20090088328A (ko) 2009-08-19
FR2927538B1 (fr) 2010-02-19
AR070416A1 (es) 2010-04-07
PT2090303E (pt) 2013-05-31
HRP20130617T1 (en) 2013-07-31
CA2654210A1 (fr) 2009-08-14
GEP20115261B (en) 2011-08-10
SI2090303T1 (en) 2013-08-30
CN101507726A (zh) 2009-08-19
CU24007B1 (es) 2014-06-27
ECSP10010402A (es) 2010-09-30
EP2090303A1 (fr) 2009-08-19
IL207386A0 (en) 2010-12-30
JP2009191069A (ja) 2009-08-27
DK2090303T3 (da) 2013-07-29
CA2654210C (fr) 2013-06-25
AU2009200393A1 (en) 2009-09-03
MY149122A (en) 2013-07-15
CY1114113T1 (el) 2016-07-27
US20090209515A1 (en) 2009-08-20
ZA200900894B (en) 2009-12-30
EA200900137A1 (ru) 2009-10-30
HN2010001608A (es) 2013-10-07

Similar Documents

Publication Publication Date Title
SG179085A1 (en) Pi3 kinase inhibitors and uses thereof
PH12013500870A1 (en) Heterocyclic compounds and uses thereof
PH12012501346A1 (en) Heteroaryl compounds and uses thereof
MX2012004780A (es) Inhibidores de akt.
PL2278958T3 (pl) Kompozycje do doustnego dostarczania kortykosteroidów
ZA201202691B (en) Disulfo-type fluorescent whitening agent compositions
IL199941A0 (en) Compositions of stable tiacumicins
PA8792401A1 (es) Fenilendiaminas
PL2304107T3 (pl) Kompozycje fluorescencyjnego środka wybielającego
ZA201203012B (en) Solid pharmaceutical compositions containing an intergrase inhibitor
MY149433A (en) Nutritional compositions containing punicalagins
GB202104969D0 (en) Fragrance composition
MX2009001590A (es) Asociacion de un inhibidor de corriente sinusal if y de un beta-bloqueante.
EP4384137A4 (en) FRAGRANCE COMPOSITIONS
MY165088A (en) Pharmaceutical compositions comprising alisporivir
IN2012DN01971A (es)
AP2006003859A0 (en) New association of a sinus node if current inhibitor and an angio-tensin-converting enzyme inhibitor, and pharmaceutical compositions containing it
GB0704087D0 (en) Fragrance compositions
MY154024A (en) Oral care compositions and methods
EP4362924A4 (en) FRAGRANCE COMPOSITION
UA27344U (en) Use of pollentar pharmaceutical composition as cerebroprotective agent
TN2010000372A1 (fr) Association d'un inhibiteur du courant if sinusal et d'un beta-bloquant
UA60035U (ru) Состав для лечения генерализованного пародонтита
AU2008900983A0 (en) Synergistic anti-inflammatory composition
UA36741U (ru) 1-фенил-4-о-толиламино-1,5-дигидропиррол-2-он, который проявляет анальгетическую и противовоспалительную активность

Legal Events

Date Code Title Description
FG Grant or registration